MFIM
LTRN icon

Mesirow Financial Investment Management’s Lantern Pharma LTRN Stock Holding History

Mesirow Financial Investment Management’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-818
Closed -$15K – 107
2021
Q1 		$15K Buy
818
+350
+75% +$6.14K 0.04% 108
2020
Q4 		$9.01K Buy
+468
New +$8.08K 0.03% 92

Other funds holding LTRN

CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mesirow Financial Investment Management's LTRN Position: Q2 2021 in Review

Mesirow Financial Investment Management sold out of Lantern Pharma (LTRN) in Q2 2021, closing a stake of 818 shares — an estimated $15K sold.

Mesirow Financial Investment Management first reported a position in LTRN in Q4 2020 and held it in 2 quarters. The position peaked at $15K in Q1 2021. 22 funds tracked by Wall St. Rank hold LTRN as of Q2 2021.

  • Mesirow Financial Investment Management reported no remaining Lantern Pharma position as of Q2 2021 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 818 Lantern Pharma shares in Q2 2021, an estimated $15K.
  • Mesirow Financial Investment Management first reported a position in Lantern Pharma in Q4 2020 and held it in 2 quarters.
  • Mesirow Financial Investment Management's Lantern Pharma position peaked at $15K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2021.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2021, filed 23 Jul 2021.